Composite and its use

• US 6,248,344 B1
• Filed: 09/17/1999
• Issued: 06/19/2001
• Est. Priority Date: 04/21/1997
• Status: Expired due to Fees

• Current Assignee: Vivoxid Oy
• Original Assignee: Antti Yli-Urpo, Hannu Aro, Kaj Karlsson, Ylänen, Heimo
• Inventors: Ylänen, Heimo, Yli-Urpo, Antti, Aro, Hannu, Karlsson, Kaj
• Primary Examiner(s): Kishore, Gollamudi S.
• Assistant Examiner(s): DI NOLA BARON, LILIANA
• Application Number:
  US09/381,229
• Time in Patent Office: 641 Days
• Field of Search: 424/422, 424/423, 424/426, 65/173, 501/1, 604/89.11, 623/11, 623/16
• US Class Current: 424/423
• CPC Class Codes: A61B 17/866 Material or manufacture
• CPC Class Codes: A61B 17/8665 Nuts
• CPC Class Codes: A61F 2/0077 Special surfaces of prostheses, e.g. for improving ingrowth A61F2/30767 takes precedence
• CPC Class Codes: A61L 27/025 Other specific inorganic materials not covered by A61L27/04 - A61L27/12
• CPC Class Codes: A61L 27/427 of other specific inorganic materials not covered by A61L27/422 or A61L27/425
• CPC Class Codes: A61P 25/34 Tobacco-abuse
• CPC Class Codes: C03C 3/097 containing phosphorus, niobium or tantalum
• CPC Class Codes: C03C 4/0007 for biologically-compatible glass
• CPC Class Codes: C03C 8/22 containing two or more distinct frits having different compositions

Abstract

A porous composite suitable for filling a recess or a through-passing hole in an implant. The composite includes particles A prepared from a bioactive material and particles B prepared from a non-bioactive material or weakly bioactive material, which is sintratable with the bioactive material, such that particles A and particles B have been sintered together to a porous composite. Particles A and particles B are essentially homogeneous in size. Also disclosed is an implant which contains a core and the composite.

Claims

1. A porous composite, which is intended to be filled into a recess or a through-passing hole of an implant, and which comprises:

particles A prepared from a bioactive material which will react in the physiological conditions within the body so that an outermost layer of a block of said bioactive material forms a chemical bond with surrounding host tissue, and

particles B, which are prepared from a non-bioactive material or from a weakly bioactive material which under physiological conditions does not dissolve within the first few months, wherein the particles A and the particles B are partially melted together to form a porous composite having a three dimensional structure in which individual particles are connected to at least one adjacent particle but retain a substantially spherical individual shape, characterized in that the particles A and B are essentially homogeneous in size, and wherein said particles A and particles B are approximately the same size compared to one another, and have a diameter of at least 250 microns.

2. The composite according to the claim 1, characterized in that the diameter of the particles A and B is in the range of 100-500 μ

m.

3. The composite according to claim 1, characterized in that the particles A and B are rounded, preferably spherical.

4. The composite according to claim 1, characterized in that the particles A are composed of bioactive glass and that the particles B are composed of glass which does not have any bioactivity or has a weak bioactivity.

5. The composite according to claim 4, characterized in that the composition of the bioactive glass is as follows:

SiO₂ 53-60% by weight

Na₂O 0-34% by weight

K₂O 1-20% by weight

MgO 0-5% by weight

CaO 5-25% by weight

B₂O₃ 0-4% by weight

P₂O₅ 0.5-6% by weight, provided that

Na₂O+K₂O=16-35% by weight

K₂O+MgO=5-20% by weight

MgO+CaO=10-25% by weight.

6. The composite according to claim 1, characterized in that the mixing ratio of particles A and B has been chosen so that the amount of particles A varies from about ⅕

to nearly {fraction (1/1)} of the total amount of the composite, preferably about ⅓

of the total amount of the composite.

13. The composite according to claim 1, characterized in that, in the sintering step, it has been formed into a block of the desired shape and size, which can be attached into the recess or the through-passing hole made into the implant core.

14. The composite according to claim 13, characterized in that the composite block is comprised of several sublayers wherein various sublayers have a distinct mixing ratio between the particles A and B so that the content of the particles A in the composite increases from the sublayer facing the implant core, towards the sublayer of the composite to come in contact with the tissue.

7. An implant comprising a core having a recess or a through-passing hole and a bioactive structural component contained within said recess or through-passing hole and which extends to the surface of the implant, wherein said bioactive structural component comprises a layer of a porous composite which comprises:

particles A prepared from a bioactive material which will react in the physiological conditions within the body so that the outermost layer of a block manufactured from said bioactive material forms a chemical bond with surrounding host tissue, and

particles B, which are prepared from a non-bioactive material or from a weakly bioactive material which under physiological conditions does not dissolve within the first few months, wherein the particles A and the particles B are partially melted together to form a porous composite having a three dimensional structure in which individual particles are connected to one at least one adjacent particle but retain a substantially spherical individual shape, characterized in that the particles A and B are essentially homogeneous in size, and wherein said particles A and particles B are approximately the same size compared to each other, and have a diameter of at least 250 microns.

8. The implant according to claim 7, characterized in that the composite layer as such is comprised of several sublayers wherein the various sublayers have a distinct mixing ratio between the particles A and B so that the content of particles A in the composite increases from the sublayer facing the implant core, towards the sublayer of the composite in contact with the tissue.

9. The implant according to claim 8, characterized in that the amount of particles A in the sublayer of the composite facing the interior of the core is {fraction (1/10)} of the amount of the sublayer in question, and that the sublayer to come in contact with the tissue, is composed exclusively or almost exclusively of particles A.

10. The implant according to claim 8, characterized in that the composite within a a recess or in a through-passing hole is manufactured so that the particles A and B are introduced into the recess or the hole and subsequently sintered.

11. The implant according to claim 8, characterized in that the particles A and B required in each of the sublayers are introduced separately into the recess or the hole and subsequently sintered.

12. The implant according to claim 8, characterized in that inert particles C, preferably prepared from the material of the core, have been sintered to the surface of the recess or the through-passing hole of the implant core before the formation of or the addition of the composite into the recess or the hole.